80 participants from CELAC and EU countries, together with supranational entities and bi-regional networks, gathered by COPOLAD in Buenos Aires. The Argentine Republic hosts the fourth edition of the series of annual meetings organized by COPOLAD in relation to the prevention and control of chemical precursors destined for the manufacture of illegal drugs, following its experience and significant participation in the activities developed within the framework of the programme.

COPOLAD brings together 15 CELAC countries in Brussels to address the progress made in the field of chemical precursors, within the framework of COPOLAD. Best practices and lessons learned for the control of illicit trafficking of chemical precursors, the focus of this joint meeting. Almost twenty participants have the opportunity to visit the main European institutions present in Brussels.

More than 150 high-level representatives from more than 30 countries in Latin America, the Caribbean and the European Union will participate in the high-level conference organized by COPOLAD, EL PACcTO and EUROSOCIAL+ to be held in Montevideo on 19 and 20 September 2019.

COPOLAD II, a program led by Spain, trains experts from Latin America and the Caribbean in an innovative tool to support the planning of drug demand reduction programs. Argentina hosts representatives from nine Andean and Southern Cone countries in the first edition of this series of planning workshops using the online application "Step@atTime", which opens new possibilities for developing more effective drug demand reduction programs based on scientific evidence.

The 4th Forum for Intra-regional Dialogue on Alternative Development of COPOLAD brings together 16 Latin American and Caribbean countries in Guatemala. The importance of the integration of the gender perspective in the Alternative Development of public policies and its potential impact on women is the central topic of this meeting. The Forum presents a study, carried out within the framework of COPOLAD, which analyzes the institutional capacities necessary for the implementation of Alternative Development in countries interested in incorporating this line of action as part of their drug policies.